Key Finasteride Market Players:
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Sun Pharmaceutical Industries Ltd.
- Dr. Reddy's Laboratories Ltd.
- Mylan N.V. (Viatris Inc.)
- Cipla Ltd.
- Merck & Co., Inc. (MSD)
- Aurobindo Pharma Ltd.
- Lupin Ltd.
- Torrent Pharmaceuticals Ltd.
- Hikma Pharmaceuticals
- Sandoz (Novartis Generics Division)
- Glenmark Pharmaceuticals
- Zydus Lifesciences Ltd.
- Towa Pharmaceutical Co. Ltd.
- Apotex Inc.
- Daewoong Pharmaceutical
- Biocon Ltd.
- Abbott Laboratories
- Duopharma Biotech Berhad
- Aspen Pharmacare
The global finasteride market is driven by the top pharma players in India due to their API production capacities, competitive pricing, and export regulatory approvals. Further, the U.S. and Europe companies maintain their brand value and distribution power, while Japan and South Korea players target domestic markets. Key strategies, including backward integration in API supply chains, product launches in topical formulations, and telehealth platforms, are used by the top players to increase patient reach. Leading players such as Teva, Sun Pharma, and Mylan are utilizing partnerships, biosimilar pipelines, and regulatory fast tracks to grow in regulated markets. Government-imposed price controls and generic adoption also fuel the market dynamics.
Below is the list of some prominent players operating in the global finasteride market:
